Neurogenic Bladder and Quality of Life in Patients With Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

71 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-15

Study Completion Date

2015-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigated effects of the neurogenic bladder on the quality of life in stroke survivors. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Lower Urinary Tract Dysfunction on Clinical Manifestation in Patients With Stroke

NCT03174600

Lower Urinary Tract Symptoms

COMPLETED

Cardiopulmonary Rehabilitation in Chronic Stroke

NCT03558542

Stroke Hemiplegia

UNKNOWN NA

Activity Daily Living Performance in Patients With Stroke

NCT03723213

Stroke

UNKNOWN

Physical Activity and Related Factors in a Sample of Turkish Patients With Stroke

NCT04084002

Stroke

UNKNOWN

Does the Length of Hospital Stay for Rehabilitation Affect Functional Outcomes in Stroke Patients

NCT04700982

Stroke

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neurogenic bladder after stroke is a commonly encountered medical condition which slows down the recovery process and exacerbates the functional status of the patient. The neurogenic bladder may possibly affect the quality of life of patients with stroke.

Objectives: The aim of this study is to investigate the relationship between the quality of life and the neurogenic bladder in Turkish stroke survivors.

Methods: 71 patients with stroke were included in the study. Patients were divided into two groups: the First group consisted of patients with neurogenic bladder and the Second group consisted of patients without neurogenic bladder. Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires were applied to both groups for clinical evaluations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Complication Neurogenic Bladder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case group

Case group reported urinary complaints

Questionnaires

Intervention Type BEHAVIORAL

Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires

Control group

Control group did not have any urinary complaints.

Questionnaires

Intervention Type BEHAVIORAL

Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Short Form-36 (SF-36), Barthel Index (BI), Functional Ambulation Category (FAC), Mini-Mental Test (MMT) and Beck Depression Inventory (BDI) questionnaires

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hemorrhagic or ischemic stroke
* No previous stroke history
* Disease duration \> 6 months

Exclusion Criteria

* Patients with different stroke etiologies other than cerebrovascular events (such as traumatic and tumoral pathologies)
* Previous multiple stroke history
* Pre-stroke urinary complaints
* Previous urogenital surgery history
* Spinal Cord Injury (SCI)
* Prostate volume of \> 35ml documented with urinary ultrasonography
* Bladder outlet obstruction
* Poorly controlled Diabetes Mellitus (DM)
* Concomitant neurological diseases such as Multiple Sclerosis and Parkinson's Disease
* Anticholinergic, alpha agonist-antagonist drug use
* Sensory and global aphasia
* Severe communication impairment

Minimum Eligible Age

30 Years

Maximum Eligible Age

88 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No